PRJNA799249
Tumor-educated platelets as a promising biomarker for blood-based detection of renal cell carcinoma
This study explored the diagnostic value of TEPs in patients with renal cell carcinoma (RCC). In this dataset, 49 platelet samples from 24 patients with RCC, 12 patients with benign renal tumor, and 13 health donors were included in this study. The RNA-seq was performed using Illumina NovaSeq 6000 platform.